Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Should we treat acute HIV infection?
Meagan O'Brien
, Martin Markowitz
Research output
:
Contribution to journal
›
Article
›
peer-review
33
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Should we treat acute HIV infection?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute HIV Infection
100%
Antiretroviral Therapy
40%
HIV Patients
20%
Age of Infection
20%
Acute Infection
20%
Treatment Regimen
20%
Risk Reduction
20%
Clinical Trial Data
20%
Early Diagnosis
20%
HIV Variant
20%
Current Guidelines
20%
Long-term Clinical Outcome
20%
Clinical Literature
20%
Treatment Opportunity
20%
Public Health Perspective
20%
Transmission Risk
20%
Short-term Benefits
20%
Drug-resistant HIV
20%
Viral Set Point
20%
Delayed Therapy
20%
Medicine and Dentistry
Acute HIV Infection
100%
Human Immunodeficiency Virus
60%
Infection
40%
Public Health
20%
Clinical Trial
20%
Antiretroviral Therapy
20%
Therapy Delay
20%
Early Diagnosis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Acute HIV Infection
100%
HIV
60%
Infection
40%
Clinical Trial
20%